v3.26.1
Organizational structure (Details)
 12 Months Ended
Mar. 31, 2026
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Malaysia
Percentage of Direct/Indirect Ownership Interest 100.00% [1]
Aurigene Oncology Limited (formerly, Aurigene Discovery Technologies Limited)  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Aurigene Pharmaceutical Services Limited [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00% [1]
beta Institut gemeinnutzige GmbH [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Germany
Percentage of Direct/Indirect Ownership Interest 100.00% [2]
betapharm Arzneimittel GmbH [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Germany
Percentage of Direct/Indirect Ownership Interest 100.00% [2]
Cheminor Investments Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Dr. Reddy's Farmaceutica Do Brasil Ltda. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Brazil
Percentage of Direct/Indirect Ownership Interest 100.00%
Dr. Reddy's Laboratories (EU) Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation United Kingdom
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories (Proprietary) Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation South Africa
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories (UK) Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation United Kingdom
Percentage of Direct/Indirect Ownership Interest 100.00% [4]
Dr. Reddy's Laboratories Canada, Inc. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Canada
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Chile SPA. [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Chile
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Inc. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation U.S.A.
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Japan KK [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Japan
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Kazakhstan LLP [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Kazakhstan
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Malaysia Sdn. Bhd. [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Malaysia
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories New York, LLC. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation U.S.A.
Percentage of Direct/Indirect Ownership Interest 100.00% [5]
Dr. Reddy's Laboratories Philippines Inc. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Philippines
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories Romania Srl  
Disclosure of subsidiaries [line items]  
Country of Incorporation Romania
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories SA [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Switzerland
Percentage of Direct/Indirect Ownership Interest 100.00%
Dr. Reddy's Laboratories Taiwan Limited [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Taiwan
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories (Thailand) Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Thailand
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories LLC, Ukraine  
Disclosure of subsidiaries [line items]  
Country of Incorporation Ukraine
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's New Zealand Limited. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation New Zealand
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Srl  
Disclosure of subsidiaries [line items]  
Country of Incorporation Italy
Percentage of Direct/Indirect Ownership Interest 100.00% [6]
Dr. Reddy's Bio-Sciences Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Dr. Reddy's Laboratories (Australia) Pty. Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Australia
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories SAS [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Colombia
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Netherlands B.V. (formerly Dr. Reddy's Research and Development B.V.) [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Netherlands
Percentage of Direct/Indirect Ownership Interest 100.00% [7]
Dr. Reddy's (Beijing) Pharmaceutical Co. Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation China
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
DRES Energy Private Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 26.00% [8]
DRL Impex Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00% [9]
Dr. Reddy's Formulations Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Idea2Enterprises (India) Pvt. Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Imperial Owners and Land Possessions Private Limited (Formerly, Imperial Credit Private Limited) (Dissolved on August 5, 2025)  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Industrias Quimicas Falcon de Mexico, S.A. de CV [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Mexico
Percentage of Direct/Indirect Ownership Interest 100.00%
Kunshan Rotam Reddy Pharmaceutical Co. Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation China
Percentage of Direct/Indirect Ownership Interest 51.33% [10]
Lacock Holdings Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Cyprus
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Laboratories LLC [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Russia
Percentage of Direct/Indirect Ownership Interest 100.00% [3],[11]
Promius Pharma LLC [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation U.S.A.
Percentage of Direct/Indirect Ownership Interest 100.00% [5]
Reddy Holding GmbH [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Germany
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Reddy Netherlands B.V. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Netherlands
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Reddy Pharma Iberia SAU  
Disclosure of subsidiaries [line items]  
Country of Incorporation Spain
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Reddy Pharma Italia S.R.L. [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Italy
Percentage of Direct/Indirect Ownership Interest 100.00% [12]
Reddy Pharma SAS [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation France
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Svaas Wellness Limited (Divested on April 7, 2026)  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 100.00%
Nimbus Health Gmbh [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Germany
Percentage of Direct/Indirect Ownership Interest 100.00% [2]
Dr. Reddy's Laboratories Jamaica Limited [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation Jamaica
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
O2 Renewable Energy IX Private Limited [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 26.00% [8]
Dr. Reddy's and Nestlé Health Science Limited (formerly, Dr. Reddy's Nutraceuticals Limited)  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 51.00%
Dr. Reddy's Employees ESOS Trust [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Cheminor Employees Welfare Trust [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Dr. Reddy's Research Foundation [member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Clean Renewable Energy KK 2A Private Limited (from July 31, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation India
Percentage of Direct/Indirect Ownership Interest 26.99% [8]
Northstar Switzerland SARL (from September 30, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation Switzerland
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
North Star OpCo Limited (from September 30, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation United Kingdom
Percentage of Direct/Indirect Ownership Interest 100.00% [13]
North Star Sweden AB (from September 30, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation Sweden
Percentage of Direct/Indirect Ownership Interest 100.00% [13]
Dr. Reddy's Denmark ApS (from October 4, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation Denmark
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Dr. Reddy's Finland Oy (from December 20, 2024)  
Disclosure of subsidiaries [line items]  
Country of Incorporation Finland
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
Kunshan Rotam Reddy Medicine Company Limited [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation China
Percentage of Direct/Indirect Ownership Interest 51.33% [10],[14]
Dr. Reddy's Laboratories (Vietnam) Company Limited (From May 9, 2025)  
Disclosure of subsidiaries [line items]  
Country of Incorporation Vietnam
Percentage of Direct/Indirect Ownership Interest 100.00% [3]
[1] Indirectly owned through Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited).
[2] Indirectly owned through Reddy Holding GmbH.
[3] Indirectly owned through Dr. Reddy’s Laboratories SA.
[4] Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.
[5] Indirectly owned through Dr. Reddy’s Laboratories Inc.
[6] Indirectly owned through Reddy Pharma Italia S.R.L
[7] Indirectly owned through Reddy Netherlands B.V.
[8] Accounted for using the equity method as per IAS 28, “Investments in Associates and Joint Ventures”.
[9] Indirectly owned through Idea2Enterprises (India) Pvt. Limited.
[10] Kunshan Rotam Reddy Pharmaceutical Co. Limited and Kunshan Rotam Reddy Medicine Company Limited are subsidiaries as per the Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment in accordance with IFRS 11, “Joint Arrangements” using the equity method and does not consolidate it in the Company’s financial statements.
[11] 45.19% held directly by Dr. Reddy’s Laboratories Limited.
[12] Indirectly owned through Lacock Holdings Limited.
[13] Indirectly owned through Northstar Switzerland SARL.
[14] Indirectly owned through Kunshan Rotam Reddy Pharmaceutical Co. Limited.